Biomarkers

"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.

Descriptor ID	D015415
MeSH Number(s)	D23.101
Concept/Terms	Biomarkers Biomarkers Markers, Biological Biologic Markers Markers, Biologic Biologic Marker Marker, Biologic Marker, Biological Biological Marker Biological Markers Markers, Laboratory Markers, Laboratory Laboratory Markers Laboratory Marker Marker, Laboratory Serum Markers Serum Markers Markers, Serum Marker, Serum Serum Marker Surrogate Endpoints Surrogate Endpoints Endpoints, Surrogate Surrogate End Points End Points, Surrogate Surrogate End Point End Point, Surrogate Surrogate Endpoint Endpoint, Surrogate Markers, Clinical Markers, Clinical Clinical Markers Clinical Marker Marker, Clinical Viral Markers Viral Markers Markers, Viral Viral Marker Marker, Viral Biochemical Marker Biochemical Marker Biochemical Markers Markers, Biochemical Marker, Biochemical Markers, Immunologic Markers, Immunologic Immune Markers Markers, Immune Marker, Immunologic Immunologic Markers Immune Marker Marker, Immune Immunologic Marker Surrogate Markers Surrogate Markers Markers, Surrogate Marker, Surrogate Surrogate Marker

Below are MeSH descriptors whose meaning is more general than "Biomarkers".

Chemicals and Drugs [D]
Biological Factors [D23]
Biomarkers [D23.101]

Below are MeSH descriptors whose meaning is related to "Biomarkers".

Below are MeSH descriptors whose meaning is more specific than "Biomarkers".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.

Bar chart showing 960 publications over 31 distinct years, with a maximum of 73 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	3	3
1996	0	2	2
1997	0	5	5
1998	0	1	1
1999	0	5	5
2000	0	4	4
2001	0	2	2
2002	2	11	13
2003	2	14	16
2004	1	17	18
2005	2	14	16
2006	5	17	22
2007	3	15	18
2008	6	25	31
2009	1	25	26
2010	4	35	39
2011	5	33	38
2012	7	41	48
2013	9	23	32
2014	8	43	51
2015	5	47	52
2016	10	47	57
2017	8	52	60
2018	8	64	72
2019	12	60	72
2020	10	63	73
2021	8	40	48
2022	1	42	43
2023	2	30	32
2024	28	29	57
2025	1	3	4

Below are the most recent publications written about "Biomarkers" by people in Profiles.

Ding H, Lyu C, Karjadi C, Sunderaraman P, Young CB, Mormino EC, Low S, Devine S, Gifford K, Au R, Lin H. Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults. Sci Rep. 2025 Apr 01; 15(1):11104.

View in: PubMed
Jha M, McCarthy IR, Gelfand EV. Lipoprotein(a) - From Biomarker to Therapy: A Review for the Clinician. Am J Cardiol. 2025 Jun 15; 245:42-53.

View in: PubMed
Schneider LS, Freiesleben SD, van Breukelen G, Wang X, Brosseron F, Heneka MT, Teipel S, Kleineidam L, Stark M, Roy-Kluth N, Wagner M, Spottke A, Schmid M, Roeske S, Laske C, Munk MH, Perneczky R, Rauchmann BS, Buerger K, Janowitz D, D?zel E, Glanz W, Jessen F, Rostamzadeh A, Wiltfang J, Bartels C, Kilimann I, Schneider A, Fliessbach K, Priller J, Spruth EJ, Hellmann-Regen J, Peters O. Linking higher amyloid beta 1-38 (A?(1-38)) levels to reduced Alzheimer's disease progression risk. Alzheimers Dement. 2025 Feb; 21(2):e14545.

View in: PubMed
Rade JJ, Kronsberg SS, Kickler TS, Vasan RS, Xanthakis V, Nayor MG, Barton BA. Association of Systemic Thromboxane Generation With Risk of Developing Heart?Failure. J Am Coll Cardiol. 2025 Jan 07; 85(1):58-70.

View in: PubMed
Kloske CM, Mahinrad S, Barnum CJ, Batista AF, Bradshaw EM, Butts B, Carrillo MC, Chakrabarty P, Chen X, Craft S, Da Mesquita S, Dabin LC, Devanand D, Duran-Laforet V, Elyaman W, Evans EE, Fitzgerald-Bocarsly P, Foley KE, Harms AS, Heneka MT, Hong S, Huang YA, Jackvony S, Lai L, Guen YL, Lemere CA, Liddelow SA, Martin-Pe?a A, Orr AG, Quintana FJ, Ramey GD, Rexach JE, Rizzo SJS, Sexton C, Tang AS, Torrellas JG, Tsai AP, van Olst L, Walker KA, Wharton W, Tansey MG, Wilcock DM. Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference. Alzheimers Dement. 2025 Jan; 21(1):e14291.

View in: PubMed
Nagy A, Eichler F, Bley A, Bredow J, Fay A, Townsend EL, Leiro B, Shaywitz A, Laforet G, Crippen-Harmon D, Williams R. Urine N-Acetylaspartate Distinguishes Phenotypes in Canavan Disease. Hum Gene Ther. 2024 Jan; 36(1-2):45-56.

View in: PubMed
Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Dec 04; 31(17):2046-2055.

View in: PubMed
Stark M, Wagner M, Kuhn E, B?rger K, D?zel E, Hellmann-Regen J, Heneka MT, Laske C, Perneczky R, Peters O, Priller J, Schmid M, Schneider A, Spottke A, Teipel S, Wiltfang J, Jessen F, Kleineidam L. Clinical Manifestations. Alzheimers Dement. 2024 Dec; 20 Suppl 3:e091377.

View in: PubMed
Arab JP, D?az LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M, Bataller R, Burton R, Chokshi S, Francque SM, Krag A, Lackner C, Lee BP, Liangpunsakul S, MacClain C, Mandrekar P, Mitchell MC, Morgan MY, Morgan TR, Pose E, Shah VH, Shawcross D, Sheron N, Singal AK, Stefanescu H, Terrault N, Tr?po E, Moreno C, Louvet A, Mathurin P. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. J Hepatol. 2025 Apr; 82(4):744-756.

View in: PubMed
Coats CJ, Masri A, Barriales-Villa R, Abraham TP, Brinkley DM, Claggett BL, Hagege A, Hegde SM, Ho CY, Kulac IJ, Lee MMY, Maron MS, Olivotto I, Owens AT, Solomon SD, Tfelt-Hansen J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Januzzi JL. Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial. Eur Heart J. 2024 Nov 08; 45(42):4464-4478.

View in: PubMed

People

Explore

Similar Concepts

Top Journals